changed Source changed

A new raw object was archived. Both versions are preserved. 4 line(s) added, 4 line(s) removed.

Evidence

Source	FDA — Press Announcements
Agency	FDA
URL	https://www.fda.gov/news-events/newsroom/press-announcements
Observed by	Civic Memory, directly, on 2026-08-26T18:28:54+00:00
Content type	text/html; charset=UTF-8
Current object	`f9b225d70675a6609bdac855289084b052cf0b48e9501cbb37b3aacbc17eadf4` download raw metadata
Previous object	`1e3f85a211d8a04d1d43bdd26f599df79dba105fd2bd27fb71d255dbfd4c0c71` download raw metadata

What changed derived

This diff is not evidence. It was produced by civic-memory.diff_engine 1.1.0 at 2026-08-26T18:28:54+00:00 by normalizing the two archived objects above. The objects are authoritative; this reading of them can be regenerated or deleted without loss. 4 line(s) added, 4 line(s) removed.

--- previous
+++ current
@@ -144,6 +144,10 @@
 
 August 2026
 
+August 26, 2026
+
+ - FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
+
 August 25, 2026
 
  - FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar
@@ -181,10 +185,6 @@
 July 29, 2026
 
  - FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
-
-July 22, 2026
-
- - FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot
 
 Pagination